
Siemens Healthineers and Sana Kliniken Collaborate to Develop AI-Powered Healthcare Solutions
Siemens Healthineers and Sana Kliniken have entered into a strategic collaboration to accelerate the development of artificial intelligence (AI)-powered healthcare solutions, with an initial focus on lung cancer screening. The partnership aims to combine clinical data, medical expertise, AI technologies and real-world clinical testing to support improved diagnostics, more personalized treatment approaches and the advancement of digital healthcare innovation in Europe.
Under the agreement, Sana Data Solutions GmbH, a subsidiary of Sana Kliniken AG, will provide curated healthcare data from Germany through a secure and controlled data environment. The data will be used as a component in training AI-powered algorithms and developing software solutions designed to address clinical needs.
The collaboration is intended to establish an environment where healthcare software can be developed, evaluated and tested more efficiently while adhering to regulatory requirements, patient privacy protections and data security standards. By bringing together healthcare data and technological expertise, the companies aim to strengthen the development of clinically relevant AI solutions that can eventually be integrated into healthcare settings.
The initiative reflects the growing importance of artificial intelligence in medical diagnostics, clinical decision-making and personalized healthcare. Healthcare organizations are increasingly exploring AI technologies to help physicians analyze complex medical information, identify patterns in diagnostic data and support the delivery of more targeted treatment strategies.
Combining Clinical Expertise With Artificial Intelligence
The partnership brings together Siemens Healthineers’ expertise in medical technology, imaging and AI-based healthcare solutions with Sana Kliniken’s clinical experience and access to healthcare data. The companies believe that combining technological capabilities with data generated in real clinical environments will help create software solutions that are more closely aligned with the needs of healthcare professionals and patients.
Clinical relevance is an important consideration in developing AI applications for healthcare. Algorithms must be trained using appropriate datasets and evaluated against the realities of medical practice, including the complexity of patient conditions, diagnostic workflows and variations in clinical information.
Stefan Schaller, Head of the Central and Western Europe region at Siemens Healthineers, highlighted the importance of connecting technological innovation with healthcare delivery.
According to Schaller, data-driven innovation can make a meaningful difference in healthcare when it is developed close to clinical practice and supported by clear governance principles. The collaboration with Sana Kliniken is intended to establish a framework that brings clinical relevance and responsible implementation together.
The companies aim to ensure that AI development is not limited to theoretical research or technology demonstrations. Instead, the partnership will focus on developing solutions that can be evaluated in clinical environments and potentially support healthcare professionals in their everyday work.
Sana Data Solutions to Provide Curated German Healthcare Data
Sana Data Solutions GmbH will play a central role in the collaboration by providing curated healthcare datasets from Germany. The company will make data available through a secure, controlled environment designed to support AI development while maintaining appropriate safeguards for sensitive healthcare information.
The datasets are expected to include a range of medical information relevant to the development of AI-powered applications. These will include clinical and pathological datasets, medical images, annotations and radiology reports.
In later stages, the data may also include additional patient context, examination results and sequences of medical examinations. The inclusion of different types of information could help researchers and developers better understand complex relationships between clinical findings, diagnostic results and patient characteristics.
Healthcare data is particularly valuable for artificial intelligence because it can help algorithms identify patterns that may be difficult to recognize through traditional manual analysis. However, the use of such data requires careful management, particularly when dealing with sensitive patient information.
Sana Data Solutions will therefore support the project through data curation, defined usage purposes and governance processes intended to ensure that data is handled responsibly and securely.
Michael Hübner, Managing Director of Sana Data Solutions GmbH, said AI-powered analysis could help reveal complex medical relationships with greater depth and speed than manual analysis alone.
He explained that the insights generated through these analyses could support the development of innovations across diagnostics, therapy and personalized care pathways. The partnership will focus on translating these insights into practical healthcare applications while maintaining clear governance, defined purposes and strong patient data protections.
Lung Cancer Screening Selected as the Initial Project
The first project under the collaboration will focus on developing AI-powered algorithms for lung cancer screening. Lung cancer remains an important area of medical research and early detection, with diagnostic imaging playing a significant role in identifying suspicious findings and supporting further clinical assessment.
As part of the initiative, Sana Kliniken and its affiliated radiology facilities will provide anonymized medical data to Siemens Healthineers. The company will use the datasets to train AI-powered algorithms designed for lung cancer screening applications.
The initial datasets are expected to include medical imaging information alongside associated annotations and radiology reports. These different data elements can provide additional context for AI systems during development and training.
The development of AI-powered screening tools may help support the analysis of medical images and assist healthcare professionals in identifying findings that require further investigation. By examining relevant patterns across large datasets, AI algorithms could potentially contribute to more efficient diagnostic workflows.
The companies intend to develop solutions that support medical professionals rather than replace clinical expertise. The technologies are expected to be evaluated in terms of their clinical relevance, performance and suitability for integration into healthcare workflows.
The lung cancer screening project will serve as an initial step in the broader collaboration, with the potential to explore additional applications in diagnostics, therapy and personalized medicine as the partnership progresses.
Testing AI Solutions in Real-World Healthcare Environments
A key component of the collaboration will be the evaluation of AI-powered software solutions in real-world clinical settings. Following the development and training of algorithms, the partners aim to assess the technologies in the day-to-day clinical environments of Sana Kliniken and its affiliated radiology practices.
Real-world testing is expected to provide an opportunity to evaluate how AI tools perform within existing healthcare workflows. This includes understanding how software solutions interact with diagnostic processes, how they support healthcare professionals and whether they can be integrated into clinical and practice environments effectively.
Testing AI applications in actual healthcare settings is an important step toward understanding their practical value. While algorithms may demonstrate promising capabilities during development, their implementation in hospitals and medical practices requires consideration of workflow requirements, clinical responsibilities, technical integration and regulatory obligations.
The partnership is intended to help shorten the development and evaluation process for medically relevant software products. By creating an environment where data, algorithm development and clinical evaluation are connected, the companies aim to facilitate the earlier testing of AI-powered tools and workflows.
The evaluation process will also help the partners assess the potential benefits of the technologies for diagnostic capabilities and treatment planning. The companies expect the initiative to support faster and improved diagnostic processes and contribute to more personalized treatment recommendations.
Supporting Personalized Healthcare and More Precise Treatment
Personalized healthcare is one of the major objectives of the collaboration. Medical treatment increasingly involves considering a patient’s individual medical history, diagnostic findings, clinical characteristics and other relevant information when determining appropriate care.
AI-powered technologies could help healthcare professionals process and analyze these different information sources, potentially supporting more informed clinical decisions.
The collaboration aims to explore how data-driven insights can be translated into solutions for diagnostics, therapy and personalized care pathways. The partners expect the development of AI-powered tools to support the identification of medically relevant patterns and provide additional information that can assist healthcare professionals.
In the context of lung cancer screening, AI-based analysis could support the examination of medical imaging data and help clinicians assess findings more efficiently. The broader objective is to develop solutions that contribute to well-founded diagnoses and treatment approaches that are more closely tailored to individual patients.
The companies also intend to examine how AI technologies can be applied within existing healthcare systems without compromising the quality of care, patient safety or the responsibilities of medical professionals.
Data Protection and Responsible AI Development
The use of healthcare data is central to the project, making data protection and responsible AI development important priorities for both organizations.
The partnership will operate through a secure and controlled data environment. The datasets provided for the initial lung cancer screening project will be anonymized, while comprehensive security concepts are intended to support high standards of data protection and data security.
The partners have also emphasized the importance of clear governance structures, defined purposes for data usage and safeguards for patients and their information.
Responsible AI development in healthcare requires more than access to data. It also involves ensuring that datasets are appropriately curated, that technologies are developed for clearly defined medical purposes and that software solutions are evaluated in the context of applicable regulatory requirements.
By establishing these principles within the collaboration, Siemens Healthineers and Sana Kliniken aim to create a framework for developing healthcare AI applications that combines technological innovation with responsible data management.
The approach is expected to support the development of medical software that can be evaluated for practical clinical use while maintaining appropriate safeguards throughout the development process.
Advancing European Healthcare Innovation and Data Sovereignty
The collaboration also has a broader objective of strengthening Europe’s position in healthcare technology innovation. According to the companies, similar AI development projects have often relied on healthcare datasets originating outside Europe.
By using curated healthcare data from Germany, the partnership aims to contribute to the development of AI-powered medical technologies using European data resources. The initiative is expected to support innovation within Europe while strengthening the region’s capabilities in healthcare AI research and development.
European data sovereignty has become an increasingly important consideration in digital healthcare, particularly as organizations seek to develop advanced technologies while maintaining control over healthcare information and complying with regional regulatory frameworks.
The partnership is intended to demonstrate how healthcare providers and medical technology companies can work together to develop data-driven innovations within a secure and controlled environment.
Through the collaboration, Siemens Healthineers and Sana Kliniken aim to contribute to Germany’s position as an innovation hub and support the advancement of European digital healthcare technologies.
Building a Foundation for Future AI Applications
The initial lung cancer screening project represents the first step in a broader collaboration between the two organizations. By combining curated healthcare data, AI development capabilities and clinical evaluation, the partnership aims to establish a foundation for additional digital healthcare innovations.
The focus will remain on developing medically relevant software solutions that can be evaluated in clinical practice, support healthcare professionals and contribute to more personalized patient care.
As artificial intelligence continues to expand across healthcare, collaborations between technology companies and healthcare providers are expected to play an important role in translating digital innovation into practical clinical applications.
The Siemens Healthineers and Sana Kliniken partnership seeks to address this opportunity by bringing together data, technology, clinical expertise and responsible implementation. Through their joint efforts, the companies aim to accelerate the development of AI-powered healthcare solutions, improve diagnostic capabilities and contribute to the future of personalized medicine in Europe.
The initiative highlights the importance of developing healthcare AI not only through technological advancements but also through clinical collaboration, secure data access and real-world evaluation—key elements in bringing digital healthcare innovation closer to everyday medical practice.
Source link: https://www.siemens-healthineers.com/





